RecallDepth
Class III Terminated

Olanzapine Tablets, 7.5 mg, packaged in a) 30-count bottles (NDC 62756-553-83), b) 100-count bottles (NDC 62756-553-88), and c) 1000-count bottles (NDC 62756-553-18), Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389, 350 Gujarat, India.

Company
Sun Pharmaceutical Industries, Inc.
Recall Initiated
March 22, 2017
Posted
May 17, 2017
Recall Number
D-0700-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
6,138 bottles
Firm Location
Cranbury, NJ, United States

Reason for Recall

Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).

Distribution

Nationwide in the USA and Puerto Rico

Lot / Code Info

Lot #: a) JKP3150B, Exp 06/17, JKR5749A, Exp 06/18; b) JKP2757A, Exp 05/17, JKP3149A, JKP3150A, Exp 06/17, JKR5049A, Exp 04/18; c) JKP2758B, Exp 05/17

More recalls by Sun Pharmaceutical Industries, Inc.

View all recalls by this company →

Other recent Class III Drug recalls